Huasen Pharmaceutical: Shareholders holding more than 5% of the company's shares reduce their holdings by 2,486,900 shares.

Huasen Pharmaceuticals announced that shareholder Liu Xiaoying, who owns more than 5% of the shares, reduced the company's shares by 2.4869 million shares through centralized bidding from March 17 to March 26, 2026, accounting for 0.60% of the total share capital of the company. After this equity change, Liu Xiaoying holds 33.4078 million shares of the company, accounting for 8% of the total share capital. This reduction is within the disclosed plan and has not been fully implemented yet, so it will not lead to a change in control rights or have a significant impact on the company's operations.